Spots Global Cancer Trial Database for bi 754091
Every month we try and update this database with for bi 754091 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread | NCT03166631 | Neoplasms Neoplasm Metast... Carcinoma, Non-... | BI 891065 BI 754091 | 18 Years - | Boehringer Ingelheim | |
| Platform Trial Evaluating Safety and Efficacy of BI 754091 Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours | NCT03697304 | Neoplasm Metast... | BI 754091 BI 754111 BI 836880 | 18 Years - | Boehringer Ingelheim | |
| A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours | NCT02952248 | Neoplasms | BI 754091 | 18 Years - | Boehringer Ingelheim | |
| Platform Trial Evaluating Safety and Efficacy of BI 754091 Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours | NCT03697304 | Neoplasm Metast... | BI 754091 BI 754111 BI 836880 | 18 Years - | Boehringer Ingelheim | |
| Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer | NCT04046445 | Colorectal Canc... MSS Stage IV Colon ... Stage IV Rectal... Metastatic Colo... Liver Metastasi... | ATP128 BI 754091 VSV-GP128 | 18 Years - | Amal Therapeutics | |
| This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091 | NCT03780725 | Carcinoma, Non-... Head and Neck N... | BI 754111 [89Zr]Zr-BI 754... BI 754091 | 18 Years - | Boehringer Ingelheim | |
| A Study to Test Different Doses of BI 765063 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer (Solid Tumors) | NCT04653142 | Solid Tumors | BI 765063 BI 754091 | 20 Years - | Boehringer Ingelheim | |
| A Study to Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer | NCT04499352 | Anal Canal Squa... | BI 754091 BI 836880 | 18 Years - | Boehringer Ingelheim | |
| This Study Aims to Find a Safe and Effective Dose of BI 754091. The Study Also Aims to Find Safe and Effective Doses of BI 754091 and BI 754111 in Combination. This Study is Done in Asian Patients With Different Types of Cancer | NCT03433898 | Neoplasms | BI 754091 BI 754111 | 18 Years - | Boehringer Ingelheim | |
| A Study to Find the Best Dose of BI 836880 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer | NCT03972150 | Neoplasms | BI 836880 BI 754091 | - | Boehringer Ingelheim | |
| This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091 | NCT03780725 | Carcinoma, Non-... Head and Neck N... | BI 754111 [89Zr]Zr-BI 754... BI 754091 | 18 Years - | Boehringer Ingelheim |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
